FCX-007 could be the first major medical advance for recessive dystrophic epidermolysis bullosa, or RDEB, in decades.
Modern medicine – dermatology
Tag Archives: advancing
Gene therapy trial for blistering skin condition advancing to next phase
FCX-007 could be the first major medical advance for recessive dystrophic epidermolysis bullosa, or RDEB, in decades.
Dermatology Times – Dermatology